Hoag Sleep Health Program


Pickup Family Neurosciences Institute's Sleep Health Program was among the first centers in Orange County dedicated to studying and treating patients with sleep disorders and has now been serving the community for over the past 20 years.

The Judy & Richard Voltmer Sleep Center at Hoag Health Center, Newport Beach has expanded to meet the growing needs of the sleep disorders patients within the community. A newly built Hoag Sleep Center at Hoag Health Center, Irvine opened in April 2017. With four private bedrooms to conduct sleep studies, each room is designed to feel like a high-quality hotel. The katest diagnostic equipment from CareFusion meets and exceeds the American Academy of Sleep Medicine guidelines. Sleep patterns can be evaluated throughout the night or day at both sleep centers. Our physicians are sleep medicine specialists that can diagnose and treat various sleep disorders such as insomnia, narcolepsy, obstructive sleep apnea, periodic limb movement disorder/Restless legs syndrome, and REM sleep behavior disorder. The program also offers a highly effective outpatient behavioral treatment course for insomnia.

Program achievements include accreditation from the American Academy of Sleep Medicine.


The Sleep Disorders Program is led by our Program Director Jose Puangco, M.D. (neurologist) and is joined by Ahmed El-Bershawi, M.D. (Pulmonary Medicine) in 2017. The program has four additional board-certified sleep physicians giving patients a choice in sleep specialists with varying backgrounds, including critical care, pulmonary, and neurology specialists. Our team of physicians is supported by highly skilled polysomnography technologists. In 2017, the sleep disorders program saw the addition of a sleep disorders care navigator to support patients in journey through the sleep disorders centers.

Adult Sleep Studies

Hoag Sleep Health Program saw 1,672 new patients in consultation which was a 10% increase from last year and 3,104 returning patients. The clinics performed 652 diagnostic polysomnography studies (PSG), 338 split night PSG studies, 137 PSG studies with a full night dedicated PAP titration (CPAP, BPAP, ASV), 4 PSG studies classified as other (including Oral Appliance Therapy or Inspire Therapy titrations), 24 Multiple Sleep Latency Tests (MSLT) and Maintenance Wakefulness Tests (MWT) and 677 home sleep studies which is an 20% increase from last year for all types of sleep testing.

Obstructive Sleep Apnea

According to the American Academy of Sleep Medicine, It is estimated that nearly 30 million adults in the U.S. have obstructive sleep apnea, which is a sleep-related breathing disorder characterized by repetitive episodes of complete or partial upper airway obstruction occurring during sleep. One treatment option for obstructive sleep apnea is continuous positive airway pressure (CPAP) therapy, which uses mild levels of air pressure, provided through a mask, to keep the throat open while you sleep.

Along with traditional methods of treating obstructive sleep apnea, the program has adopted new treatment methods. For the treatment of Obstructive Sleep Apnea, the sleep disorders program is working in collaboration with local dentists to provide Oral Appliance Therapy. Additionally, Dr. Puangco continues to be the only provider of the Inspire Medical Device in Orange County, giving patients a surgical option for the treatment of Obstructive Sleep Apnea.


Insomnia disorder is defined in the International Classification of Sleep Disorders, Third Edition as a complaint of trouble initiating or maintaining sleep which is associated with daytime consequences and is not attributable to environmental circumstances or inadequate opportunity to sleep. The disorder is identified as chronic when it has persisted for at least three months at a frequency of at least three times per week.

Hoag Sleep Health Program offers a six-week insomnia program. This program is designed to break the pattern of insomnia through cognitive behavioral therapy and teach participants coping techniques to alleviate their insomnia and improve quality of life. Participants are assessed through questionnaires in Week 1 and again on Week 6 to show the progress made with the program. The Insomnia Severity Index has seven questions asking the participants to identify how severe they feel their insomnia is in specific areas. Participants are also asked to report changes in average sleep time and rate their quality of sleep.

On average, participants experienced a six-point drop in the Insomnia Severity Index after participation in the program. Sixty-seven percent of patients reported an increase in average sleep time per night with 79 percent reporting better sleep quality.

Support & Education

As a member of American Sleep Apnea Association, the sleep disorders program offers a monthly AWAKE Sleep Apnea Support Group for CPAP users, which meets the last Tuesday of each month from 2 to 3 p.m.

With sleep disorders having a strong prevalence among other conditions, the program has sponsored speakers at Stroke Support Groups, Parkinson’s Disease Support Group, Better Breathers Club, Brain Aneurysm/AVM support group and a monthly speaker for Chemical Dependency patients. With sleep disorders having a strong prevalence among other conditions, the program has sponsored speakers at Stroke Support Groups, Parkinson’s Disease Support Group, Better Breathers Club, Brain Aneurysm/AVM support group and a monthly speaker for Addiction Treatment patients.

The program has also hosted an annual sleep medicine symposium for polysomnography technologists to assist the local community with staying current on the latest technologies and research.

Quality Assurance

The standards for accreditation by the American Academy of Sleep Medicine mandate a rigorous scoring quality assurance program comparing the scoring of Registered Polysomnographic Technologists with a gold standard of board certified sleep physicians with an inter-scorer reliability greater than 85%.

To learn more, visit the Sleep Health Program section or call 949-764-8070.